A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux

@article{Wei2016AMF,
  title={A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux},
  author={Chunhui Wei},
  journal={European Archives of Oto-Rhino-Laryngology},
  year={2016},
  volume={273},
  pages={3795-3801}
}
  • Chunhui Wei
  • Published 16 June 2016
  • Medicine
  • European Archives of Oto-Rhino-Laryngology
We aimed to systematically review the randomized controlled trials (RCTs) regarding the therapeutic efficiency of proton pump inhibitor (PPI) therapy for laryngopharyngeal reflux (LPR). Randomized and placebo-controlled trials regarding the therapeutic efficacy of PPIs on LPR patients were systematically searched from MEDLINE, Cochrane Library, and EMBASE. Data were extracted from eligible studies meeting the inclusion criteria. Heterogeneity among these eligible studies was evaluated by the Q… 

Effect of Proton Pump Inhibitors on Reflux Symptom Index (RSI) and Reflux Finding Score (RFS) in Patients with Laryngopharyngeal Reflux: A Systematic Review and Meta-Analysis

A meta-analysis found that, although a statistically significant benefit in RSI was noted with PPI therapy, this difference may not translate to a clinically significant change in symptoms; therefore, there is insufficient evidence to recommend for or against the treatment of LPR with PPIs.

Meta-analysis of Proton Pump Inhibitors in the Treatment of Pharyngeal Reflux Disease

Overall efficiency, reflux symptom index (RSI), reflux finding score (RFS), improvement in cough and hoarseness, and adverse reactions were compared using the Review Manager 5.3 and the PPI group showed significant improvement compared with the placebo group.

A Prospective Randomized Clinical Trial of Combination Therapy with Proton Pump Inhibitors and Mucolytics in Patients with Laryngopharyngeal Reflux

Combination therapy with mucolytics and PPI compared to PPI alone did not lead to faster or more effective symptomatic relief in LPR patients.

Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial

Alginate was non-inferior to PPI and may represent an alternative treatment to PPIs for the treatment of LPR.

Proton pump inhibitors effect on the quality of life of patients with laryngopharyngeal reflux

ABSTRACTBackground: Laryngopharyngeal reflux (LPR) is a condition caused by retrograde flow of gastric contents to the larynx, pharynx, trachea, and bronchus, which can affect patients’ quality of

Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal reflux

Therapeutic trial seems to be an effective way of initial management of patients with anticipated LPR which can be used after the cause of the problems is ruled out by other specialists.

Alternatives to Acid Suppression Treatment for Laryngopharyngeal Reflux

Mixed evidence with a high degree of bias and heterogeneity between studies for the modalities presented in the paper means an anti-reflux diet is recommended for all patients and there is some low-quality evidence to support alkaline water.

The Indications, Applications, and Risks of Proton Pump Inhibitors.

  • J. Mössner
  • Medicine
    Deutsches Arzteblatt international
  • 2016
PI are among the more effective drugs for the treatment of diseases associated with gastric acid and should only be prescribed for scientifically validated indications, in view of their cost and potential adverse effects.

Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression

Overall, PPIs are irreplaceable drugs in the management of acid-related diseases, however, PPI treatment, as any kind of drug therapy, is not without risk of adverse effects.

References

SHOWING 1-10 OF 26 REFERENCES

Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial.

  • P. LamM. Ng B. Wong
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2010

Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux

Proton Pump Inhibitor Therapy for Chronic Laryngo-Pharyngitis: A Randomized Placebo-Control Trial

  • D. StewardK. Wilson J. Welge
  • Medicine
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • 2004

[The therapeutic effect of proton pump inhibitor on alleviation of hoarseness symptoms in patients with laryngopharyngeal reflux].

PPI therapy could significantly alleviate the hoarseness symptom in LPR patients.

Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial

Empirical treatment with lansoprazole is efficacious in relieving symptoms of laryngeal symptoms compared to placebo and can be considered as a first-line option in managing patients with idiopathic chronic laryngitis.

Double-Blind, Placebo-Controlled Trial with Single-Dose Pantoprazole for Laryngopharyngeal Reflux

Response was similar between single-dose pantoprazole and placebo in newly diagnosed LPR, and results suggested that laryngeal exam was not useful in following treatment response.

A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough

It is suggested that the best diagnostic and therapeutic approach, after excluding asthma and postnasal drip syndrome, is empiric treatment for 2 wk with a high dose proton pump inhibitor.

Effect of Pantoprazole on the Course of Reflux-Associated Laryngitis: a Placebo-Controlled Double-Blind Crossover Study

The self-limited nature of reflux-associated laryngitis in non-smokers is largely underestimated and pantoprazole may be helpful especially in relieving acute symptoms, but the advantage of long-term treatment over placebo has been greatly overestimated.

Efficacy of once-daily esomeprazole treatment in patients with laryngopharyngeal reflux evaluated by 24-hour pH monitoring

Evaluation of Omeprazole in the Treatment of Reflux Laryngitis: A Prospective, Placebo‐Controlled, Randomized, Double‐Blind Study

The objective of this study was to determine the efficacy of omeprazole in treating proven reflux laryngitis.